Innovation
The Value of Vaccines: Ensuring Australia keeps pace with community values and international practice
The role of the community in engaging on vaccination issues is essential
Our people
Karyn and Ahmed Trek for Kids
Two employees from Australia and New Zealand join 38 of their global colleagues to Trek for Kids in support of Save the Children in Ethiopia
Patients & consumers
Living every day with COPD
Over 1.4 million Australians are living with Chronic Obstructive Pulmonary Disease, or COPD, with as many as one in 20 people over the age of 55 affected by the condition. Although understanding of COPD has improved significantly in recent years, we are constantly seeking new avenues to explore in our relentless pursuit for better breathing.
Innovation
Pulling back the curtain on the PBS
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
Patients & consumers
Crowd sourcing new treatments for malaria
New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.
Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Our people
Employees helping communities
Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.
Patients & consumers
International collaboration seeks to make childbirth safer in developing countries
A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries
Our people
Save the Children
GSK and Save the Children have the goal of helping to save the lives of one million children by sharing medical and humanitarian expertise.